Genedrive Share Discussion Threads

[snowy20] 13/6/2022 11:02

Buys picking up .

[milanr] 13/6/2022 10:57

So no sales and revenue this year too . How are they going to pay CEOs salary for his brilliant job ?

[snowy20] 13/6/2022 10:47

› insphealthcare

[milanr] 13/6/2022 10:25

Any sales ?

[snowy20] 13/6/2022 10:08

Well financed this year. approx £6 million in bank number months past. NHS AIHL RNS even this week or soon ,Good chance Back to £1 ,50K buyer buying so many shares

[snowy20] 13/6/2022 10:06

Catch up with progress
Around 300 nurses are being trained to use the machine across MFT at Saint Mary’s Hospital, Wythenshawe Hospital, and North Manchester General Hospital, and the test is expected to be routinely used in all the hospitals’ neonatal units within weeks, which are part of Saint Mary’s Managed Clinical Service within the Trust.




Watch for HVC RNS & AIHL RNS .High chance quid when NHS sales RNS .

NHS update Due .

[milanr] 10/6/2022 16:14

Big buys today, it is about to explode , next stop 10p

[master rsi] 10/6/2022 14:34

Covid-19 infections in UK show early signs of increase
(Alliance News) - Covid-19 infections in the UK are no longer falling, with some parts of the country showing early signs of a possible increase, figures showed.

The rise is likely to have been caused by a jump in infections compatible with the original Omicron variant BA.1, along with the newer variants BA.4 and BA.5.

It comes as separate figures suggest the recent drop in the number of people in hospital with Covid-19 may also have come to a halt.

A total of 989,800 people in private households in the UK are estimated to have had the virus in the week ending June 2, up from 953,900 the previous week, according to the Office for National Statistics.

It is the first time total infections have risen week-on-week since the end of March, when the number hit a record 4.9 million at the peak of the Omicron BA.2 wave.

All four nations have seen a slight rise in the prevalence of the virus, though the ONS describes the trend in Scotland and Wales as "uncertain".

In England, 797,500 people were likely to test positive for Covid-19 last week – the equivalent of around one in 70.

This is up week-on-week from 784,100, which was also around one in 70.

Northern Ireland has seen infections rise for the second week in a row to stand at 27,700 people, or one in 65, up from 24,300 people, or one in 75.

In Scotland, 124,100 people were likely to have had the virus last week, or one in 40, up from 105,900, or one in 50.

Wales has seen Covid-19 infections increase very slightly to an estimated 40,500 people, or one in 75, up from 39,600, also one in 75.

"Across all four UK countries, the percentage of people testing positive for Covid-19 compatible with Omicron variants BA.1, BA.4 and BA.5 increased in the week ending June 2, 2022," the ONS said.

Omicron BA.1 is the original variant of Omicron that caused a surge in infections across the UK in December and early January.

BA.4 and BA.5 are newer variants that were recently classified by the UK Health Security Agency as "variants of concern", after analysis found both were likely to have a "growth advantage" over BA.2, which is still the dominant strain in the country.

Initial findings suggest BA.4 and BA.5 have a degree of "immune escape" – meaning the immune system can no longer recognise or fight a virus – which is likely to contribute to their growth advantage over BA.2, the UK Health Security Agency said.

The latest estimates for Covid-19 infections come as separate figures show the recent fall in the number of people in hospital with the virus may have come to a stop.

Some 4,082 patients in England had Covid-19 on June 9, up 6% on the previous week, while in Scotland 637 patients were recorded on June 5 – the latest date available – up 8% week-on-week.

Patient numbers in both nations had previously been on a steady downwards trend since early April, following the peak of the Omicron BA.2 wave.

In Wales and Northern Ireland, the figures for people in hospital with the virus have levelled off in recent days.

[snowy20] 10/6/2022 14:15

Well financed this year. approx £6 million in bank number months past. NHS AIHL RNS even this week or soon ,Good chance Back to £1 ,50K buyer recently buying so many shares

[snowy20] 10/6/2022 14:10

Catch up with progress
Around 300 nurses are being trained to use the machine across MFT at Saint Mary’s Hospital, Wythenshawe Hospital, and North Manchester General Hospital, and the test is expected to be routinely used in all the hospitals’ neonatal units within weeks, which are part of Saint Mary’s Managed Clinical Service within the Trust.




Watch for HVC RNS & AIHL RNS .High chance quid when NHS sales RNS .

NHS update Due .



Into news time .If not this day .Watch for news soon .

[snowy20] 10/6/2022 09:23

Lotta buys.

[snowy20] 10/6/2022 08:49

Minister for Innovation, Lord Kamall, said: “Genomics is changing the future of healthcare – from detecting new variants of Covid to enabling more targeted treatment of illness.

“This innovative new test has the potential to prevent life altering and preventable side effects for babies and keep the NHS ahead of the curve in delivering state of the art care.

“The UK continues to lead the way in genomics expertise and is paving the way for earlier diagnosis of conditions in children and faster access to the right treatment”.

[snowy20] 10/6/2022 08:48

David Budd, CEO of Genedrive, said: “There is a significant drive within the NHS to alert healthcare professionals to the impact of antibiotic-induced hearing loss and encourage them to consider genetic testing prior to initiation of treatment.

“It’s a great example of using human genetics to guide specific therapy, which is now taking front and centre in clinical management globally. The application of Genedrive’s technology shows how a rapid, affordable, point-of-care test could impact patients’ treatment and quality of life across this as well as a wide range of fields”

[snowy20] 10/6/2022 08:26

Catch up with progress
Around 300 nurses are being trained to use the machine across MFT at Saint Mary’s Hospital, Wythenshawe Hospital, and North Manchester General Hospital, and the test is expected to be routinely used in all the hospitals’ neonatal units within weeks, which are part of Saint Mary’s Managed Clinical Service within the Trust.




Watch for HVC RNS & AIHL RNS .High chance quid when NHS sales RNS .

NHS update Due .

[snowy20] 10/6/2022 08:26

To read views of these people .Why I invested .high chance of big rise .news due .

[snowy20] 10/6/2022 08:23

Mike Hobday, Director of Policy and Campaigns at the National Deaf Children’s Society, said: “The National Deaf Children’s Society welcomes the publication of this important study. The introduction of a rapid test to identify susceptibility to deafness caused by the antibiotic gentamicin will be greatly valued by many families of newborn babies.

“Up to now the genetic test has taken too long to return from the lab to be useful for babies requiring urgent treatment but a rapid test will be a game-changer”

[snowy20] 10/6/2022 08:23

Professor Newman, who is Associate Lead, Hearing Health Genomic Solutions at NIHR Manchester Biomedical Research Centre (BRC), said the team had successfully transferred the accuracy of the machine in the lab to working effectively in a ward. At the same time, clinicians adapted quickly to incorporate the test into their routine care for very sick children in the neonatal ward.

The idea for the test came five years ago, and trials started in 2020 with further adaptations and fine-tuning so that the current machine, which is called the Genedrive System, is now fully CE certified to be used in a clinical setting.

Study results were published in JAMA Pediatrics – the top-ranked paediatrics journal in the world – last week.

Backed by £900,000 funding from the National Institute for Health Research (NIHR) and support from the charity Royal National Institute for Deaf People, the Genedrive System, which costs £80 per baby, was developed by Genedrive, a start-up based at the University of Manchester. It was developed in close collaboration with Professor Newman’s team at Manchester Biomedical Research Centre.

[snowy20] 10/6/2022 08:22

Professor Dame Sue Hill, Chief Scientific Officer for England and Senior Responsible Officer for Genomics in the NHS, said: “Genomic medicine is transforming healthcare, and this is a powerful example of how genetic testing can now be done extremely quickly and become a vital part of triage – not only in intensive care but across our services.

“It also shows the importance of thinking about how advances in technology can rapidly transform how we use genomics closer to care for our patients.”

[blackhorse23] 09/6/2022 14:43

I have no confidence at GDR , moved to IGR , revenue close to billion

[snowy20] 09/6/2022 13:16

ITV Video AIHL .

[snowy20] 09/6/2022 13:04

around 300 nurses are being trained to use the machine across MFT at Saint Mary’s Hospital, Wythenshawe Hospital, and North Manchester General Hospital, and the test is expected to be routinely used in all the hospitals’ neonatal units within weeks, which are part of Saint Mary’s Managed Clinical Service within the Trust.




Watch for HVC RNS & AIHL RNS .High chance quid when NHS sales RNS .

NHS update Due

[snowy20] 09/6/2022 12:59

Missed number of buys showing in sells .

[snowy20] 09/6/2022 12:58

Buys filling up .

[snowy20] 09/6/2022 12:56

Blue .Is news on way .